US HB2423 | 2015-2016 | 114th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on May 19 2015 - 25% progression, died in committee
Action: 2015-05-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 19 2015 - 25% progression, died in committee
Action: 2015-05-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence. This bill amends the Federal Food, Drug, and Cosmetic Act to define “valid scientific evidence” to include well-documented case histories or studies published in peer-reviewed journals for purposes of the Food and Drug Administration (FDA) determining the effectiveness of a medical device without clinical investigation. Under specified conditions, the FDA may request the data underlying a study that is offered as valid scientific evidence.
Title
To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence.
Sponsors
Rep. John Shimkus [R-IL] |
History
Date | Chamber | Action |
---|---|---|
2015-05-22 | House | Referred to the Subcommittee on Health. |
2015-05-19 | House | Referred to the House Committee on Energy and Commerce. |
2015-05-19 | House | Introduced in House |
Same As/Similar To
HB6 (Related) 2015-07-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Drug safety, medical device, and laboratory regulation
Health
Health technology, devices, supplies
Scientific communication
Health
Health technology, devices, supplies
Scientific communication
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/114th-congress/house-bill/2423/all-info |
Text | https://www.congress.gov/114/bills/hr2423/BILLS-114hr2423ih.pdf |